Puma Biotech has only retained commercial rights to its cancer drug Nerlynx in the U.S. and Japan after a series of licensing deals. But even the remaining U.S. launch doesn’t seem to be going well. In the first quarter, Nerlynx ginned up sales of $ 45.6 million, Puma said Thursday. That’s way below analyst expectations of… Read More: Puma Biotech’s new cancer drug Nerlynx suffered a terrible quarter.… »
After a lull in enforcement actions concerning HIPAA, the Office for Civil Rights re-entered the fray with a $ 3 million fine. The settlement, announced on May 6, imposes a significant fine after widespread non-compliance was found by OCR. As with many prior settlements, the factual scenario underpinning the latest settlement is fairly egregious. As… Read More: Why organizations ignore HIPAA at their own peril »
A dentist using a tablet integrated with on-site dental equipment showing a dental x-ray on a tablet. Photo credit: Getty Getty As a parent of two small children, getting them into brushing is not as easy as I would have thought. Kids love water, mirrors, and playing, but somehow getting my three-year-old into brushing his teeth is no easy feat. Then I… Read More: Virtual Dentistry And The Culture Of Technological Control – Forbes »
Among adults with mental health needs, those covered by Medicare or employer-sponsored health insurance have greater access to medical treatment, less out-of-pocket cost and are more likely to receive care than those seeking an appointment through an Affordable Care Act marketplace-sponsored plan, according to findings from researchers at Drexel University’s Dornsife School of Public Health.… Read More: Mental health patients insured by marketplace health plan less likely… »